Itron (NASDAQ:ITRI) SVP Sells $18,223.92 in Stock

Itron, Inc. (NASDAQ:ITRIGet Free Report) SVP Justin Patrick sold 216 shares of Itron stock in a transaction dated Tuesday, May 26th. The shares were sold at an average price of $84.37, for a total transaction of $18,223.92. Following the completion of the transaction, the senior vice president directly owned 32,709 shares of the company’s stock, valued at $2,759,658.33. This trade represents a 0.66% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Itron Trading Down 1.3%

Itron stock opened at $82.48 on Friday. The company has a quick ratio of 2.24, a current ratio of 2.66 and a debt-to-equity ratio of 0.97. The firm has a 50-day moving average price of $87.71 and a two-hundred day moving average price of $93.73. The firm has a market capitalization of $3.66 billion, a price-to-earnings ratio of 13.15, a PEG ratio of 0.73 and a beta of 1.35. Itron, Inc. has a 52-week low of $77.77 and a 52-week high of $142.00.

Itron (NASDAQ:ITRIGet Free Report) last posted its earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.23. The firm had revenue of $586.98 million during the quarter, compared to analyst estimates of $572.04 million. Itron had a net margin of 12.31% and a return on equity of 19.54%. Itron’s revenue was down 3.3% on a year-over-year basis. During the same period in the previous year, the business posted $1.52 EPS. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. Sell-side analysts expect that Itron, Inc. will post 6.01 earnings per share for the current year.

Wall Street Analysts Forecast Growth

ITRI has been the subject of a number of research analyst reports. Raymond James Financial assumed coverage on shares of Itron in a research note on Tuesday, April 21st. They issued an “underperform” rating for the company. TD Cowen cut their price target on shares of Itron from $145.00 to $130.00 and set a “buy” rating on the stock in a report on Wednesday, April 29th. Guggenheim set a $155.00 price target on shares of Itron in a report on Friday, February 13th. Needham & Company LLC started coverage on shares of Itron in a research report on Friday, March 6th. They issued a “buy” rating and a $124.00 target price for the company. Finally, Zacks Research upgraded shares of Itron from a “strong sell” rating to a “hold” rating in a research report on Thursday, February 26th. Eight investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $131.22.

Read Our Latest Analysis on ITRI

Institutional Trading of Itron

A number of hedge funds have recently bought and sold shares of ITRI. Northwestern Mutual Wealth Management Co. boosted its holdings in Itron by 343.6% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company’s stock valued at $46,000 after purchasing an additional 268 shares during the period. M&T Bank Corp increased its position in shares of Itron by 10.0% during the 2nd quarter. M&T Bank Corp now owns 2,141 shares of the scientific and technical instruments company’s stock worth $282,000 after purchasing an additional 194 shares in the last quarter. EverSource Wealth Advisors LLC increased its position in shares of Itron by 25.3% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock worth $53,000 after purchasing an additional 81 shares in the last quarter. Jump Financial LLC acquired a new stake in shares of Itron during the 2nd quarter worth about $1,609,000. Finally, Cerity Partners LLC increased its position in shares of Itron by 10.2% during the 2nd quarter. Cerity Partners LLC now owns 5,431 shares of the scientific and technical instruments company’s stock worth $715,000 after purchasing an additional 503 shares in the last quarter. 96.19% of the stock is owned by institutional investors.

Itron Company Profile

(Get Free Report)

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.

Featured Articles

Insider Buying and Selling by Quarter for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.